Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05126459
Other study ID # 5190213
Secondary ID
Status Completed
Phase Phase 3
First received
Last updated
Start date February 14, 2022
Est. completion date April 12, 2023

Study information

Verified date November 2023
Source Loma Linda University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will compare the post sedation events from three different multi-drug oral sedation regimens in order to help pediatric dentists determine the best course of action for their patients and prepare parents appropriately and caution them about the expected effects. Patients will be evaluated for adverse effects within two time periods at 8 and 24 hours post oral sedation procedure using surveys.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date April 12, 2023
Est. primary completion date April 11, 2023
Accepts healthy volunteers No
Gender All
Age group 3 Years to 6 Years
Eligibility Inclusion Criteria: - Patients scheduled to undergo oral sedation appointments in Loma Linda University Pediatric dental clinic for operative procedures. - Age 3-6 years, Healthy ( ASA-1 ) - No gender, race or ethnic restrictions. - Reason for conscious oral sedation is situational anxiety in the dental operatory Exclusion Criteria: - Children with a history of acute illness - History upper respiratory tract infection within two weeks of treatment - Children taking any medication within the two weeks prior to scheduled dental treatment - Sedation within the last six months - Body mass index (BMI) greater than the 95th percentile for their age and sex - Failing to drink the entire amount of sedation medications dispensed

Study Design


Related Conditions & MeSH terms


Intervention

Combination Product:
Regimen 1
Administer orally after informed consent obtained prior to any dental procedure. Hydroxyzine (1.5- 2mg/kg) + Meperidine (1.5 -2 mg/kg) + Midazolam (0.5- 0.75 mg/kg) In combination with oral drugs stated above, administeration via inhalation of Nitrous oxide/oxygen (30-50% N2O/ 70-50% O2) via inhalation.
Regimen #2
Administer orally after informed consent obtained prior to any dental procedure. Hydroxyzine (1.5 - 2mg/kg) + Meperidine (1.5 -2 mg/kg). Administer Nitrous oxide/oxygen (30-50% N2O/ 70-50% O2) via inhalation.
Regimen #3
Administer orally after informed consent obtained prior to any dental procedure. Hydroxyzine (1.5 - 2mg/kg) + Midazolam (0.5- 0.75 mg/kg). Administer Nitrous oxide/oxygen (30-50% N2O/ 70-50% O2) via inhalation.

Locations

Country Name City State
United States Loma Linda University Loma Linda California

Sponsors (1)

Lead Sponsor Collaborator
Loma Linda University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Incidence of Adverse Sedation-Related Events in Regimen #1 Compare the incidence of adverse sedation related events (categories: amount and frequency of sleeping, level of activity, gastrointestinal discomfort, central nervous system, respiratory depression, paradoxical reactions) between three different multi-agent oral sedation regimens in LLUSD pediatric dental patients who were scheduled for oral sedation.
Data will be collected in the form of 3 survey sets: the surveys is survey set 1 are written surveys to be completed by the dentist (Survey 1), and survey sets 2&3 are phone surveys to be conducted by the researcher with the parents 8 (eight) hours (Survey 2) and 24 (twenty-four) hours (Survey 3) after discharge.
Change between 8 (eight) hours post oral sedation medication administration and discharge and 24 (twenty-four) hours post oral sedation medication administration and discharge.
Primary Incidence of Adverse Sedation-Related Events in Regimen #2 Compare the incidence of adverse sedation related events (categories: amount and frequency of sleeping, level of activity, gastrointestinal discomfort, central nervous system, respiratory depression, paradoxical reactions) between three different multi-agent oral sedation regimens in LLUSD pediatric dental patients who were scheduled for oral sedation.
Data will be collected in the form of 3 survey sets: the surveys is survey set 1 are written surveys to be completed by the dentist (Survey 1), and survey sets 2&3 are phone surveys to be conducted by the researcher with the parents 8 (eight) hours (Survey 2) and 24 (twenty-four) hours (Survey 3) after discharge.
Change between 8 (eight) hours post oral sedation medication administration and discharge and 24 (twenty-four) hours post oral sedation medication administration and discharge.
Primary Incidence of Adverse Sedation-Related Events in Regimen #3 Compare the incidence of adverse sedation related events (categories: amount and frequency of sleeping, level of activity, gastrointestinal discomfort, central nervous system, respiratory depression, paradoxical reactions) between three different multi-agent oral sedation regimens in LLUSD pediatric dental patients who were scheduled for oral sedation.
Data will be collected in the form of 3 survey sets: the surveys is survey set 1 are written surveys to be completed by the dentist (Survey 1), and survey sets 2&3 are phone surveys to be conducted by the researcher with the parents 8 (eight) hours (Survey 2) and 24 (twenty-four) hours (Survey 3) after discharge.
Change between 8 (eight) hours post oral sedation medication administration and discharge and 24 (twenty-four) hours post oral sedation medication administration and discharge.
Secondary Compare incidence of adverse effect related to the use of three medications versus two medications Compare the number and type of adverse effect related (Amount and frequency of sleeping, level of activity, gastrointestinal discomfort, central nervous system, respiratory depression, paradoxical reactions) to the use of three medications versus two medications.
Data will be collected in the form of 3 survey sets: the surveys is survey set 1 are written surveys to be completed by the dentist (Survey 1), and survey sets 2&3 are phone surveys to be conducted by the researcher with the parents 8 (eight) hours (Survey 2) and 24 (twenty four) hours (Survey 3) after discharge
24 (twenty-four) hours post oral sedation medication administration (composite measurement)
See also
  Status Clinical Trial Phase
Completed NCT05584696 - Effectiveness of Green Color Exposure on Dental Anxiety N/A
Not yet recruiting NCT03229720 - Evaluation of Audio-Visual Distraction Technique on Child's Anxiety N/A
Not yet recruiting NCT06116994 - The Effect of Using Camouflaged Dental Syringe N/A
Not yet recruiting NCT05908981 - The Effects of Sandalwood Aromatherapy on Anxiety Levels of Pediatric N/A
Recruiting NCT05585905 - Virtual Reality in Pediatric Dentistry N/A
Terminated NCT03943836 - Reducing Anxiety in Pediatric Dental Patients Through Passive Music Therapy N/A
Not yet recruiting NCT03872934 - Effect of Different Music Types on Implant Surgery Anxiety
Recruiting NCT05405088 - Identification of Predictive Factors of Postoperative Pain After Oral Surgery From Phenotypic Parameters Easily Accessible Preoperatively (PHEDOPO) N/A
Recruiting NCT04942145 - Effect of Virtual Reality on Dental Patients N/A
Not yet recruiting NCT04215055 - Comparative Evaluation Between the Effectiveness of Vibration Assisted Syringe and Conventional Syringe N/A
Recruiting NCT04609956 - Virtual Reality Technology on Pain Perception and Anxiety Levels in Adolescents and Young Adults During Third Molar Germ Avulsion Surgery (VIDAMO) N/A
Not yet recruiting NCT06133868 - The Efficacy of Lavender and Chamomile Essential Oils Inhalation in Management of Dental Anxiety and Pain in Children Undergoing Local Anesthesia Administration and Primary Tooth Extraction N/A
Completed NCT04762654 - Turkish Version of Modified Child Dental Anxiety Scale